Psilocybin addiction recovery research links immune system inflammation shifts, not brain biomarkers alone, to stronger treatment response and reduced substance use risk

Psilocybin addiction recovery may depend as much on the immune system as on the brain. The reported study found that the strongest signal associated with recovery was not a purely neural marker, but changes tied to inflammation and immune activity, suggesting that psychedelic treatment effects may involve whole-body biology. Addiction is increasingly understood as a condition shaped by stress, inflammation, and disrupted regulation across brain and body systems. In that context, psilocybin appears relevant not only for subjective psychological change but also for biological pathways linked to craving, resilience, and repair. Immune-related findings could matter for how future treatments are designed, measured, and personalized. Biomarkers beyond brain scans may help identify who benefits most, clarify mechanisms of action, and expand psychedelic medicine from a narrow neuroscience model toward an integrated neuroimmune framework for recovery.